DMKJ
BBIO icon

David M. Knott Jr’s BridgeBio Pharma BBIO Stock Holding History

David M. Knott Jr’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.92M Buy
92,850
+2,850
+3% +$200K 3.66% 7
2026
Q1 		$6.68M Buy
90,000
+5,000
+6% +$362K 3.98% 4
2025
Q4 		$6.5M Hold
85,000
– – 3.01% 7
2025
Q3 		$4.41M Buy
85,000
+5,000
+6% +$244K 1.78% 12
2025
Q2 		$3.45M Buy
+80,000
New +$2.91M 1.57% 13
2024
Q3 		– Sell
-21,000
Closed -$532K – 93
2024
Q2 		$532K Buy
21,000
+5,000
+31% +$137K 0.21% 49
2024
Q1 		$495K Buy
16,000
+4,000
+33% +$136K 0.18% 53
2023
Q4 		$484K Buy
12,000
+3,000
+33% +$90.1K 0.19% 46
2023
Q3 		$237K Buy
+9,000
New +$255K 0.09% 65
2022
Q4 		– Sell
-143,096
Closed -$1.42M – 174
2022
Q3 		$1.42M Sell
143,096
-70,110
-33% -$728K 0.6% 40
2022
Q2 		$1.94M Buy
213,206
+12,313
+6% +$103K 0.81% 29
2022
Q1 		$2.04M Buy
+200,893
New +$2.06M 0.65% 40

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

David M. Knott Jr's BBIO Position: Q2 2026 in Review

David M. Knott Jr increased its BridgeBio Pharma (BBIO) stake by 3.2% in Q2 2026, buying an estimated $200K and bringing the position to 92,850 shares worth $6.92M. The position accounts for 3.66% of the portfolio, ranked #7.

David M. Knott Jr first reported a position in BBIO in Q1 2022 and has held it in 12 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • David M. Knott Jr held 92,850 shares of BridgeBio Pharma worth $6.92M as of Q2 2026.
  • David M. Knott Jr bought 2,850 BridgeBio Pharma shares in Q2 2026, an estimated $200K.
  • BridgeBio Pharma made up 3.66% of David M. Knott Jr's portfolio in Q2 2026, its #7 holding.
  • David M. Knott Jr first reported a position in BridgeBio Pharma in Q1 2022 and has held it in 12 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.